NDC product
Etonogestrel/Ethinyl Estradiol
NDC 66993-605 · Prasco Laboratories
Key facts
| Product NDC | 66993-605 |
|---|---|
| Proprietary name | Etonogestrel/Ethinyl Estradiol |
| Nonproprietary name | etonogestrel and ethinyl estradiol |
| Substances | ETONOGESTREL, ETHINYL ESTRADIOL |
| Dosage form | INSERT, EXTENDED RELEASE |
| Route | VAGINAL |
| Labeler | Prasco Laboratories |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Application number | NDA021187 |
| Pharmacologic classes | Estrogen Receptor Agonists [MoA], Estrogen [EPC], Progesterone Congeners [CS], Progestin [EPC] |
| Marketing start | Jun 1, 2021 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: